Drugs & Targets FDA approves Imjudo + Imfinzi and platinum-based chemo for metastatic NSCLC November 11, 2022Vol.48 No.41
Drugs & Targets FDA approves Adcetris + chemo for pediatric classical Hodgkin lymphoma November 11, 2022Vol.48 No.41
Drugs & Targets Portage Biotech, Merck to collaborate on clinical trial November 11, 2022Vol.48 No.41
Drugs & Targets FDA issues draft guidance on expanded access to investigational drugs November 04, 2022Vol.48 No.40
Drugs & Targets Carrum Health and AccessHope partner to increase access to cost-effective cancer expertise November 04, 2022Vol.48 No.40
Drugs & Targets FDA approves Imjudo in combination with Imfinzi for unresectable hepatocellular carcinoma October 28, 2022Vol.48 No.39
Drugs & Targets FDA denies marketing application for menthol e-cigarettes October 28, 2022Vol.48 No.39
Drugs & Targets FDA publishes final guidance on drug development for AML October 21, 2022Vol.48 No.38
